BCL2A1 and hepatocellular carcinoma: As shown in Figures 5(a) and 5(b), the miR-587 inhibitor significantly upregulated BCL2A1 expression, and Sh-PANTR1#1 inhibited BCL2A1 expression in HCC cells (∗P < 0.05 and ∗∗P < 0.01), which suggest that BCL2A1 might be a target for miR-587.